Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
1-androstenedione
- Development stage
- Unknown
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
1-Androstenedione is a synthetic anabolic steroid and a metabolite of 1-testosterone. It acts as a prohormone, being converted in the body to more active androgens such as testosterone. Like other anabolic steroids, it is used with the intent to increase muscle mass, strength, and athletic performance. However, its efficacy for these purposes has not been conclusively demonstrated in scientific studies. In the United States, 1-androstenedione is regulated as a Schedule III controlled substance due to its potential for abuse and health risks associated with anabolic steroids[1]. It is primarily intended for research and forensic applications rather than medical use.
- Other names
- 1-androstenedione
02
Targets
AR (Adrenergic receptors)ER (Estrogen receptor)
Beyond the preview
Go deeper on 1-androstenedione.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 1-androstenedione.